168 related articles for article (PubMed ID: 21508169)
1. Increased CXC ligand 10 levels and gene expression in type 1 leprosy reactions.
Scollard DM; Chaduvula MV; Martinez A; Fowlkes N; Nath I; Stryjewska BM; Kearney MT; Williams DL
Clin Vaccine Immunol; 2011 Jun; 18(6):947-53. PubMed ID: 21508169
[TBL] [Abstract][Full Text] [Related]
2. Cortisol and proinflammatory cytokine profiles in type 1 (reversal) reactions of leprosy.
Chaitanya VS; Lavania M; Nigam A; Turankar RP; Singh I; Horo I; Sengupta U; Jadhav RS
Immunol Lett; 2013; 156(1-2):159-67. PubMed ID: 24189521
[TBL] [Abstract][Full Text] [Related]
3. Is CXCL10/CXCR3 axis overexpression a better indicator of leprosy type 1 reaction than inducible nitric oxide synthase?
Sharma I; Singh A; Mishra AK; Singh LC; Ramesh V; Saxena S
Indian J Med Res; 2015 Dec; 142(6):681-9. PubMed ID: 26831417
[TBL] [Abstract][Full Text] [Related]
4. Longitudinal immune responses and gene expression profiles in type 1 leprosy reactions.
Geluk A; van Meijgaarden KE; Wilson L; Bobosha K; van der Ploeg-van Schip JJ; van den Eeden SJ; Quinten E; Dijkman K; Franken KL; Haisma EM; Haks MC; van Hees CL; Ottenhoff TH
J Clin Immunol; 2014 Feb; 34(2):245-55. PubMed ID: 24370984
[TBL] [Abstract][Full Text] [Related]
5. In situ T regulatory cells and Th17 cytokines in paired samples of leprosy type 1 and type 2 reactions.
Costa MB; Hungria EM; Freitas AA; Sousa ALOM; Jampietro J; Soares FA; Stefani MMA
PLoS One; 2018; 13(6):e0196853. PubMed ID: 29883464
[TBL] [Abstract][Full Text] [Related]
6. Potential plasma markers of Type 1 and Type 2 leprosy reactions: a preliminary report.
Stefani MM; Guerra JG; Sousa AL; Costa MB; Oliveira ML; Martelli CT; Scollard DM
BMC Infect Dis; 2009 May; 9():75. PubMed ID: 19473542
[TBL] [Abstract][Full Text] [Related]
7. Autophagy-Associated IL-15 Production Is Involved in the Pathogenesis of Leprosy Type 1 Reaction.
Silva BJA; Bittencourt TL; Leal-Calvo T; Mendes MA; Prata RBDS; Barbosa MGM; Andrade PR; Côrte-Real S; Sperandio da Silva GM; Moraes MO; Sarno EN; Pinheiro RO
Cells; 2021 Aug; 10(9):. PubMed ID: 34571865
[TBL] [Abstract][Full Text] [Related]
8. Cytokine and protein markers of leprosy reactions in skin and nerves: baseline results for the North Indian INFIR cohort.
Lockwood DN; Suneetha L; Sagili KD; Chaduvula MV; Mohammed I; van Brakel W; Smith WC; Nicholls P; Suneetha S
PLoS Negl Trop Dis; 2011 Dec; 5(12):e1327. PubMed ID: 22180790
[TBL] [Abstract][Full Text] [Related]
9. High levels of inflammatory cytokines are associated with poor clinical response to steroid treatment and recurrent episodes of type 1 reactions in leprosy.
Manandhar R; Shrestha N; Butlin CR; Roche PW
Clin Exp Immunol; 2002 May; 128(2):333-8. PubMed ID: 11985524
[TBL] [Abstract][Full Text] [Related]
10. Severe type 1 upgrading leprosy reaction in a renal transplant recipient: a paradoxical manifestation associated with deficiency of antigen-specific regulatory T-cells?
Vieira AP; Trindade MAB; de Paula FJ; Sakai-Valente NY; Duarte AJDS; Lemos FBC; Benard G
BMC Infect Dis; 2017 Apr; 17(1):305. PubMed ID: 28438129
[TBL] [Abstract][Full Text] [Related]
11. Potential Role of CXCL10 in Monitoring Response to Treatment in Leprosy Patients.
Ferreira H; Mendes MA; de Mattos Barbosa MG; de Oliveira EB; Sales AM; Moraes MO; Sarno EN; Pinheiro RO
Front Immunol; 2021; 12():662307. PubMed ID: 34354699
[TBL] [Abstract][Full Text] [Related]
12. Role of TEFFECTOR/MEMORY Cells, TBX21 Gene Expression and T-Cell Homing Receptor on Type 1 Reaction in Borderline Lepromatous Leprosy Patients.
Dos Santos LN; da Silva PH; Alvim IM; Nery JA; Lara FA; Sarno EN; Esquenazi D
PLoS One; 2016; 11(10):e0164543. PubMed ID: 27764137
[TBL] [Abstract][Full Text] [Related]
13.
Das M; David D; Horo I; Van Hooij A; Tió-Coma M; Geluk A; Vedithi SC
Front Microbiol; 2023; 14():1113318. PubMed ID: 37051521
[TBL] [Abstract][Full Text] [Related]
14. The histological diagnosis of leprosy type 1 reactions: identification of key variables and an analysis of the process of histological diagnosis.
Lockwood DN; Lucas SB; Desikan KV; Ebenezer G; Suneetha S; Nicholls P
J Clin Pathol; 2008 May; 61(5):595-600. PubMed ID: 18326022
[TBL] [Abstract][Full Text] [Related]
15. Age is an important risk factor for onset and sequelae of reversal reactions in Vietnamese patients with leprosy.
Ranque B; Nguyen VT; Vu HT; Nguyen TH; Nguyen NB; Pham XK; Schurr E; Abel L; Alcaïs A
Clin Infect Dis; 2007 Jan; 44(1):33-40. PubMed ID: 17143812
[TBL] [Abstract][Full Text] [Related]
16. Gene set signature of reversal reaction type I in leprosy patients.
Orlova M; Cobat A; Huong NT; Ba NN; Van Thuc N; Spencer J; Nédélec Y; Barreiro L; Thai VH; Abel L; Alcaïs A; Schurr E
PLoS Genet; 2013; 9(7):e1003624. PubMed ID: 23874223
[TBL] [Abstract][Full Text] [Related]
17. Dysregulated expression of MIG/CXCL9, IP-10/CXCL10 and CXCL16 and their receptors in systemic sclerosis.
Rabquer BJ; Tsou PS; Hou Y; Thirunavukkarasu E; Haines GK; Impens AJ; Phillips K; Kahaleh B; Seibold JR; Koch AE
Arthritis Res Ther; 2011 Feb; 13(1):R18. PubMed ID: 21303517
[TBL] [Abstract][Full Text] [Related]
18. A study on histological features of lepra reactions in patients attending the Dermatology Department of the Government Medical College, Calicut, Kerala, India.
Sarita S; Muhammed K; Najeeba R; Rajan GN; Anza K; Binitha MP; Aparna G
Lepr Rev; 2013 Mar; 84(1):51-64. PubMed ID: 23741882
[TBL] [Abstract][Full Text] [Related]
19. Type 1 reaction in leprosy: a model for a better understanding of tissue immunity under an immunopathological condition.
Andrade PR; Pinheiro RO; Sales AM; Illarramendi X; Barbosa MG; Moraes MO; Jardim MR; Nery JA; Sampaio EP; Sarno EN
Expert Rev Clin Immunol; 2015 Mar; 11(3):391-407. PubMed ID: 25666357
[TBL] [Abstract][Full Text] [Related]
20. High matrix metalloproteinase production correlates with immune activation and leukocyte migration in leprosy reactional lesions.
Teles RM; Teles RB; Amadeu TP; Moura DF; Mendonça-Lima L; Ferreira H; Santos IM; Nery JA; Sarno EN; Sampaio EP
Infect Immun; 2010 Mar; 78(3):1012-21. PubMed ID: 20008541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
